Investigation of type I interferon and immune signalling in breast and ovarian cancer

Zoe R. C. Marks(Hudson Institute of Medical Research)

Journal and proceedings of the Royal Society of New South Wales

December 1, 2018

10.5962/p.361842

Cited by 0

Related Papers

Interferon-ε is a tumour suppressor and restricts ovarian cancer

|Nature|2023|70

PROPERTIES AND FUNCTIONS OF THE NOVEL TYPE I INTERFERON EPSILON

|Seminars in Immunology|2019|40